Flagship Ventures Opportunities Fund I General Partner LLC
Related Filers (26)
- AFEYAN NOUBAR (17)
- Flagship Ventures Opportunities Fund I, L.P. (17)
- Flagship Ventures Fund IV, L.P. (11)
- Flagship Ventures Fund IV General Partner LLC (11)
- Flagship Ventures Fund V, L.P. (7)
- Flagship Ventures Fund V General Partner LLC (7)
- Flagship Ventures Fund IV-Rx, L.P. (7)
- Evelo Biosciences, Inc. (5)
- Flagship Pioneering Inc. (5)
- Axcella Health Inc. (5)
- Nutritional Health Side Fund, L.P. (4)
- Nutritional Health Disruptive Innovation Fund, L.P. (4)
- Flagship VentureLabs V LLC (4)
- KANIA EDWIN M JR (4)
- Kaleido Biosciences, Inc. (4)
- Nutritional Health LTP Fund General Partner LLC (3)
- Nutritional Health LTP Fund, L.P. (3)
- Flagship V VentureLabs Rx Fund, L.P. (2)
- Flagship VentureLabs V Manager LLC (2)
- Flagship VentureLabs IV, LLC (2)
- Flagship Ventures Fund 2007, L.P. (2)
- Flagship Ventures 2007 General Partner LLC (2)
- Foghorn Therapeutics Inc. (2)
- Flagship Pioneering Special Opportunities Fund II General Partner LLC (2)
- Flagship Pioneering Special Opportunities Fund II, L.P. (2)
- Rubius Therapeutics, Inc. (1)
- Show More ...
Other (8)
13F-NT
Monday, 11/14/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/15/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/16/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 2/14/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/15/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/16/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/17/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 2/16/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
Ownership (17)
4
Monday, 10/17/2022
Axcella Health Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/1/2022
Evelo Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/18/2022
Axcella Health Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/23/2021
Rubius Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/10/2021
Kaleido Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/4/2021
Evelo Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/29/2020
Foghorn Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/22/2020
Foghorn Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 7/1/2020
Evelo Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/8/2020
Kaleido Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/20/2020
Axcella Health Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/15/2019
Axcella Health Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/8/2019
Axcella Health Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 3/6/2019
Kaleido Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/27/2019
Kaleido Biosciences, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 5/15/2018
Evelo Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 5/8/2018
Evelo Biosciences, Inc.: Initial statement of beneficial ownership of securities